1. Home
  2. Adverse drug reaction
  Subject:

Adverse drug reaction   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
 Pharmacovigilance Syndrome MEDLINE Pharmacokinetics World Health Organization PubMed Hypertension Gene Embase Causality Adverse drug reaction Algorithm Norway Protein Obesity Phenotype CINAHL Clinical trial PsycINFO Blood plasma Bioavailability Enzyme inhibitor Biological half-life Pharmacodynamics Logistic regression Confidence interval HIV India Ethiopia Cochrane Library Scopus Diabetes mellitus Diabetes mellitus type 2 DNA Polymerase chain reaction Messenger RNA Acid Granger causality Cointegration Variance
RELATED SUBJECTS:
The publications listed also have these subjects
Pharmacovigilance  7 times
MEDLINE  6 times
Syndrome  4 times
Pharmacokinetics  4 times
Embase  4 times
World Health Organization  3 times
Psychoactive drug  3 times
Odds ratio  3 times
Hypertension  3 times
Gene  3 times
Causality  3 times
Blood plasma  3 times
Sweden  2 times
Scopus  2 times
PubMed  2 times
Placebo  2 times
Pharmacodynamics  2 times
P-glycoprotein  2 times
Opioid  2 times
Metronidazole  2 times
Meta-analysis  2 times
Hyperkalemia  2 times
Hyperglycemia  2 times
Human leukocyte antigen  2 times
Hepatotoxicity  2 times
HIV  2 times
Growth factor  2 times
Disease  2 times
Cutaneous condition  2 times
Coronary artery disease  2 times
Confidence interval  2 times
Clinical trial  2 times
Central nervous system  2 times
Carbamazepine  2 times
Blood lipids  2 times
Antidepressant  2 times
Algorithm  2 times
White people  1 time
Wales  1 time
Vital capacity  1 time
Trimethoprim  1 time
Triazole  1 time
Transaminase  1 time
Titration  1 time
Thailand  1 time
Thai language  1 time
Test cricket  1 time
TaqMan  1 time
Systems biology  1 time
Systematic review  1 time
Swedish language  1 time
Sunitinib  1 time
Subcutaneous tissue  1 time
Spectroscopy  1 time
Spearman's rank correlation coefficient  1 time
Single-nucleotide polymorphism  1 time
Singapore  1 time
Semantics  1 time
Schizophrenia  1 time
SPSS  1 time
Rifampicin  1 time
Rhizome  1 time
Rheumatoid arthritis  1 time
Rhabdomyolysis  1 time
Radiation therapy  1 time
Quinolone  1 time
Qatar  1 time
Purpura  1 time
Punjab (region)  1 time
Portuguese language  1 time
Pneumonia  1 time
Platelet  1 time
Pharmacology  1 time
Peripheral neuropathy  1 time
Peptide  1 time
Peer-to-peer  1 time
Pakistan  1 time
PH  1 time
Overactive bladder  1 time
Oral mucosa  1 time
Ophthalmology  1 time
Oncology  1 time
Nomogram  1 time
Neurological disorder  1 time
Netherlands  1 time
Natural-language processing  1 time
National Health Service  1 time
NMDA receptor  1 time
Myalgia  1 time
Multivariate analysis  1 time
Multiplex polymerase chain reaction  1 time
Mozambique  1 time
Michael E. Mann  1 time
Methylenetetrahydrofolate reductase  1 time
Methotrexate  1 time
Metabolism  1 time
Melanoma  1 time
Medical Subject Headings (MeSH)  1 time
Medicaid  1 time
Major depressive disorder  1 time
Low-density lipoprotein  1 time
Liver function tests  1 time
Lipoprotein  1 time
Levetiracetam  1 time
Lamotrigine  1 time
Ivermectin  1 time
Italy  1 time
Isoniazid  1 time
Ionic strength  1 time
International Statistical Classification of Diseases and Related Health Problems  1 time
Immunosuppression  1 time
Immunoglobulin therapy  1 time
Idiopathic pulmonary fibrosis  1 time
Hypotension  1 time
Hyponatremia  1 time
Hypoesthesia  1 time
Hyperlipidemia  1 time
Hypercholesterolemia  1 time
Hormone  1 time
Hoffmann-La Roche  1 time
Heparin  1 time
Hemodialysis  1 time
Growth hormone  1 time
Google Scholar  1 time
Global Positioning System  1 time
Germ cell  1 time
Gamma-Aminobutyric acid  1 time
France  1 time
Fever  1 time
Fentanyl  1 time
Fenofibrate  1 time
European Medicines Agency  1 time
Etoposide  1 time
Ethiopia  1 time
Epileptic seizure  1 time
Epilepsy  1 time
Enzyme  1 time
Emergency medicine  1 time
Edema  1 time
Dyslipidemia  1 time
Dutch language  1 time
Drug interaction  1 time
Dental caries  1 time
Dementia  1 time
Delirium  1 time
Decision support system  1 time
Cocaine  1 time
Clinical Global Impression  1 time
Clarithromycin  1 time
Cisplatin  1 time
Chronic kidney disease  1 time
Cholesterol  1 time
Chemotherapy  1 time
Chemokine  1 time
Ceftriaxone  1 time
Cardiovascular disease  1 time
Cancer immunotherapy  1 time
Bone fracture  1 time
Bone density  1 time
Body mass index  1 time
Blood Pressures  1 time
Bleomycin  1 time
Biosimilar  1 time
Bioavailability  1 time
Bangladesh  1 time
Asteroid family  1 time
Artificial intelligence  1 time
Arthralgia  1 time
Antimicrobial resistance  1 time
Antihypertensive drug  1 time
Anticonvulsant  1 time
Antibody  1 time
Angiotensin-converting enzyme  1 time
Amplitude modulation  1 time
Allele  1 time
Alanine transaminase  1 time
Agonist  1 time
Adenosine monophosphate  1 time
Acid  1 time
Absorbance  1 time

Publications tagged with this subject: 50

Note: Top 50 publications shown only. Open an item panel to view more info


1. The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions

2. Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment

3. Safety issues related to the use of prescription drugs in patients with chronic diseases: a bibliographic review

4. Characteristics and quality of adverse drug reaction reporting: a comparison of pharmacists with other healthcare providers at a multi-specialty hospital in Qatar

5. Impact of 2015 Update to the Beers Criteria on Estimates of Prevalence and Costs Associated with Potentially Inappropriate Use of Antimuscarinics for Overactive Bladder

6. Supporting clinical rules engine in the adjustment of medication (SCREAM): protocol of a multicentre, prospective, randomised study

7. Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBase

8. Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication

9. Comparative analysis of three drug–drug interaction screening systems against probable clinically relevant drug–drug interactions: a prospective cohort study

10. Deaths from Medicines: A Systematic Analysis of Coroners’ Reports to Prevent Future Deaths

11. Investigation of antimicrobial use at a tertiary care hospital in Southern Punjab, Pakistan using WHO methodology

12. The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis

13. Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database

14. High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy

15. Cutaneous Drug Reactions in the Elderly

16. Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study

17. A Survey on Pharmacovigilance Activities in ASEAN and Selected Non-ASEAN Countries, and the Use of Quantitative Signal Detection Algorithms

18. An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list

19. Individual capacity-building approaches in a global pharmaceutical systems strengthening program: a selected review

20. The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia

21. The prevalence of medication-related adverse events in inpatients—a systematic review and meta-analysis

22. Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS

23. Use and Safety of Anthroposophic Medicinal Products: An Analysis of 44,662 Patients from the EvaMed Pharmacovigilance Network

24. Drug voyager: a computational platform for exploring unintended drug action

25. Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment)

26. Detecting Signals of Disproportionate Reporting from Singapore’s Spontaneous Adverse Event Reporting System: An Application of the Sequential Probability Ratio Test

27. Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis: Experience from 92 Sites in an Open-Label US Expanded Access Program

28. Drug-Induced Pyoderma Gangrenosum: A Review

29. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy

30. Concurrent use of alcohol interactive medications and alcohol in older adults: a systematic review of prevalence and associated adverse outcomes

31. Effect of pH and ionic strength on the binding strength of anti-PF4/polyanion antibodies

32. Attitudes and opinions of Portuguese community pharmacy professionals towards patient reporting of adverse drug reactions and the pharmacovigilance system

33. Use and safety of antiepileptic drugs in psychiatric inpatients—data from the AMSP study

34. Medication-related visits in a pediatric emergency department: an 8-years retrospective analysis

35. Comparative analysis of package inserts of local and imported antihypertensive medications in Palestine

36. Neuropsychiatric Effects of Antimicrobial Agents

37. Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS/TEN susceptibility

38. Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies

39. Ivermectin induced Steven–Johnsons syndrome: case report

40. A Head-to-Head Comparison of UK SF-6D and Thai and UK EQ-5D-5L Value Sets in Thai Patients with Chronic Diseases

41. Pooled Analysis of Four Non-Interventional Studies: Effectiveness and Tolerability of the Antidepressant Agomelatine in Daily Practice

42. No correlation between MTHFR c.677 C > T, MTHFR c.1298 A > C, and ABCB1 c.3435 C > T polymorphisms and methotrexate therapeutic outcome of rheumatoid arthritis in West Algerian population

43. Severe hypertriglyceridemia secondary to venlafaxine use in an older adult on dialysis -case report

44. Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children

45. Epidemiology and Risk Factors in Drug Hypersensitivity Reactions

46. Overview of the Safety of Anti-VEGF Drugs: Analysis of the Italian Spontaneous Reporting System

47. Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a meta-analysis of randomized controlled trials

48. Simplifying drug package leaflets written in Spanish by using word embedding

49. Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol)

50. Spontaneously Reported Adverse Reactions for Herbal Medicinal Products and Natural Remedies in Sweden 2007–15: Report from the Medical Products Agency


Questions?

Drop us a message.